🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients enrolled to the study had chronic lymphocytic leukemia (CLL) and r...
Status
Terminated
Location
University of California San Diego - Moores Cancer Center
Start Date
2018-04-09
Trial ID
NCT03400176
This study aims at elucidating the mechanism of action of ianalumab in sali...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-07-27
Trial ID
NCT05124925
Treatments Being Tested
The purpose of this study is to investigate the tolerability of ianalumab (...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2026-08-04
Trial ID
NCT07421167
Treatments Being Tested
This was a randomized, partially blinded, placebo-controlled, non-confirmat...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-12-20
Trial ID
NCT02038049
A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 s...
Status
Active Not Recruiting
Location
Providence Medical Foundation
Start Date
2022-08-04
Trial ID
NCT05349214
The purpose of this study is to evaluate efficacy and safety of ianalumab c...
Status
Active Not Recruiting
Location
Michigan Center of Medical Research
Start Date
2022-12-30
Trial ID
NCT05648968
A randomized, double-blind, placebo controlled, 2-arm multicenter phase 3 s...
Status
Completed
Location
Medvin Clinical Research
Start Date
2022-07-28
Trial ID
NCT05350072
The purpose of this pharmacokinetic (PK) study is to describe the PK profil...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-25
Trial ID
NCT06411639
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of iana...
Status
Recruiting
Location
Sun Valley Arthritis Center Ltd
Start Date
2026-07-16
Trial ID
NCT07621809
This study investigated the safety and tolerability of VAY736 administered ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-12-20
Trial ID
NCT02675803
Treatments Being Tested